Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target By Benzinga Newsdesk February 15, 7:10 AM HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target. AMLX
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target By Benzinga Newsdesk February 15, 7:05 AM HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and maintains $2 price target. BTCY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Bicycle Therapeutics, Maintains $72 Price Target By Benzinga Newsdesk February 15, 6:35 AM Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $72 price target. BCYC
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $25 Price Target By Benzinga Newsdesk February 15, 5:56 AM HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $25 price target. VALN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Neutral on Albireo Pharma, Maintains $42 Price Target By Benzinga Newsdesk February 15, 5:55 AM HC Wainwright & Co. analyst Ed Arce reiterates Albireo Pharma (NASDAQ:ALBO) with a Neutral and maintains $42 price target. ALBO
Read More 1 minute read Analyst Ratings News Price Target Reiteration Cowen & Co. Reiterates Market Perform on Restaurant Brands Intl, Maintains $72 Price Target By Benzinga Newsdesk February 15, 5:53 AM Cowen & Co. analyst Andrew Charles reiterates Restaurant Brands Intl (NYSE:QSR) with a Market Perform and maintains $72 price target. QSR
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $50 Price Target By Benzinga Newsdesk February 15, 5:44 AM HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and maintains $50 price target. CGEM
Read More 2 minute read Analyst Ratings Movers News Price Target Reiteration Tech Trading Ideas AMD Anticipates Long Term Market Share Gains In Client Computing And Data Center: Analyst By Anusuya Lahiri February 14, 3:10 PM Benchmark analyst Cody Acree maintained Advanced Micro Devices Inc (NASDAQ: AMD) with a Buy and AMD
Read More 1 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Small Cap Analyst Bumps Up Denny’s Price Target By 8% Reflecting Top-Line Momentum; Notes Limited Visibility Into Margin Recovery By Shivani Kumaresan February 14, 2:46 PM Wedbush analyst Nick Setyan reiterated a Neutral rating on the shares of Denny’s Corp (NASDAQ:DENN) and raised the price target from $12.50… DENN
Read More 1 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Rockwell Automation Analyst Sees Stock As Well Positioned Over Next Several Years By Shivani Kumaresan February 14, 2:16 PM Morgan Stanley analyst Joshua Pokrzywinski reiterated an Overweight rating on the shares of Rockwell Automation Inc (NYSE:ROK) with a price target of… ROK